Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers.
about
BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma.Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma.Clinical implications of novel activating EGFR mutations in malignant peritoneal mesothelioma.Experience with peritoneal mesothelioma at the Milan National Cancer Institute.Telomerase activity in pleural malignant mesotheliomas.A Histomorphologic Grading System That Predicts Overall Survival in Diffuse Malignant Peritoneal Mesothelioma With Epithelioid SubtypeReduction of estradiol in human malignant pleural mesothelioma tissues may prevent tumour growth, as implied by in in-vivo and in-vitro modelsIntraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients.Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this diseaseDiffuse malignant peritoneal mesothelioma: systematic review of clinical management and biological research.The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma.MR imaging features of peritoneal adenomatoid mesothelioma: a case report.Novel and existing mutations in the tyrosine kinase domain of the epidermal growth factor receptor are predictors of optimal resectability in malignant peritoneal mesothelioma.A comparison of epidermal growth factor receptor expression in malignant peritoneal and pleural mesothelioma.Epidermal growth factor receptor overexpression in malignant pleural mesothelioma: prognostic correlations.Association Between Clinicopathological Factors and Genomic Abnormalities Detected by FISH Analysis in Epithelioid Diffuse Malignant Pleural Mesothelioma.Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure.Cytologic examination of ascitic fluid in a patient with pleural-based mass: A unique presentation of a rare tumor
P2860
Q30412528-55DBA569-7812-44B7-9A97-43AFE002E766Q33755896-87FC8EA1-CFE6-47ED-A614-0853C412BD52Q34267563-598FF995-44F5-47FA-82CF-5B11316145A3Q34391082-15824669-253E-42BC-9818-9E401D46B29EQ35103570-E4839445-65D5-45AB-ADBE-2E261D1221DBQ37268597-D2E002ED-FCE3-481B-BB32-462091160C60Q37565062-EBC04D63-C3E8-4D4E-BA0E-38D61CF7B736Q37662806-1B92D274-8A90-4052-852D-D71DA00E04D4Q37686318-4A220C82-4BA0-477E-935D-4CA92DE59546Q37833952-A54841B8-0641-461D-BAAC-3E64A8BE7607Q38950690-B56980E8-0529-4C24-873D-E33CE24C48E9Q43148595-22B0E2DF-9070-4F19-952F-C73483163A50Q46255077-EE8F5970-9B79-4FBA-8B13-3988C14DC10EQ54521295-00FACE9D-131F-46D6-89FE-ED7F0BD7E0E2Q54601144-8EC46447-B43C-458C-A119-874B42CFC782Q54779306-69CB8D06-87FE-48F8-9701-D49FA081541DQ55026044-3663DBD2-CF38-462C-96F7-56705E74AA24Q58561912-76E06F59-CC48-4C62-A99B-6B4ECDCF4A3A
P2860
Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers.
@en
Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers.
@nl
type
label
Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers.
@en
Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers.
@nl
prefLabel
Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers.
@en
Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers.
@nl
P2093
P2860
P1433
P1476
Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers.
@en
P2093
Edward A Levine
Jacqueline K Trupiano
Kim R Geisinger
Mark C Willingham
Nora Zbieranski
Paul Manders
P2860
P2888
P304
P356
10.1038/MODPATHOL.3800067
P577
2004-04-01T00:00:00Z